GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE2013.05-15.85 (-0.78 %)
PREV CLOSE ( ) 2028.90
OPEN PRICE ( ) 2064.50
BID PRICE (QTY) 2013.05 (3)
OFFER PRICE (QTY) 2015.70 (3)
VOLUME 2108
TODAY'S LOW / HIGH ( )1995.40 2064.50
52 WK LOW / HIGH ( )1087 2195.75
NSE2017.00-14.7 (-0.72 %)
PREV CLOSE( ) 2031.70
OPEN PRICE ( ) 2041.20
BID PRICE (QTY) 2017.00 (15)
OFFER PRICE (QTY) 2017.90 (1)
VOLUME 42835
TODAY'S LOW / HIGH( ) 1995.00 2044.15
52 WK LOW / HIGH ( )1086.1 2194
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.